Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: N-methyl-D-aspartate receptors (NMDARs) are critical for neuronal development and synaptic plasticity. Dysregulation of NMDARs is implicated in neuropsychiatric disorders. Native NMDARs are heteromultimeric protein complexes consisting of NR1 and NR2 subunits. NR2 subunits (NR2A–D) are the major determinants of the functional properties of NMDARs. Most research has focused on NR2A- and/or NR2B-containing receptors. A recent study demonstrated that NR2C- and/or NR2D-containing NMDARs are the primary targets of memantine, a drug that is widely prescribed to treat Alzheimer’s disease. Our laboratory demonstrated that memantine prevents the loss of retinal ganglion cells (RGCs) in GLAST glutamate transporter knockout mice, a model of normal tension glaucoma (NTG), suggesting that NR2D-containing receptors may be involved in RGC loss in NTG. Results: Here we demonstrate that NR2D deficiency attenuates RGC loss in GLAST-deficient mice. Furthermore, Dock3, a guanine nucleotide exchange factor, binds to the NR2D C-terminal domain and reduces the surface expression of NR2D, thereby protecting RGCs from excitotoxicity. Conclusions: These results suggest that NR2D is involved in the degeneration of RGCs induced by excitotoxicity, and that the interaction between NR2D and Dock3 may have a neuroprotective effect. These findings raise the possibility that NR2D and Dock3 might be potential therapeutic targets for treating neurodegenerative diseases such as Alzheimer’s disease and NTG.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular determinants of NMDA receptor internalization
Roche, K. W., Standley, S., McCallum, J., Dune Ly, C., Ehlers, M. D., & Wenthold, R. J. (2001) · Nature Neuroscience · doi:10.1038/90498 · Cited by 550 · cited 1×
“Because NMDARs undergo regulated endocytosis [24-26], overexpression of Dock3 may reduce glutamate-induced Ca elevation and apoptosis in RGCs by reducing the number of NMDARs on the cell surface.”
BackgroundNMDA receptor trafficking through an interaction between PDZ proteins and the exocyst complex
Sans, N., Prybylowski, K., Petralia, R. S., Chang, K., Wang, Y.-X., Racca, C., Vicini, S., & Wenthold, R. J. (2003) · Nature Cell Biology · doi:10.1038/ncb990 · Cited by 327 · cited 1×
“Multiple studies show that protein-protein interactions involving the intracellular C-terminal domains of NMDARs control the function and localization of these receptors [17-20].”
BackgroundPrion protein attenuates excitotoxicity by inhibiting NMDA receptors
Khosravani, H., Zhang, Y., Tsutsui, S., Hameed, S., Altier, C., Hamid, J., Chen, L., Villemaire, M., Ali, Z., Jirik, F. R., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200711002 · Cited by 275
Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271 · cited 2×
“Recently, it was demonstrated that Mg regulates the sensitivity of NMDARs to memantine, a drug that is widely prescribed for the treatment of Alzheimer’s disease [11].”
BackgroundChi, Z.-L., Akahori, M., Obazawa, M., Minami, M., Noda, T., Nakaya, N., Tomarev, S., Kawase, K., Yamamoto, T., Noda, S., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq146 · Cited by 151 · cited 1×
“Eyes from mice at postnatal day 35 (P35) were enucleated, fixed in Davidson’s solution fixative [41] overnight at 4°C, and dehydrated in 70% ethanol for three days at 4°C.”
MethodDock3 induces axonal outgrowth by stimulating membrane recruitment of the WAVE complex
Namekata, K., Harada, C., Taya, C., Guo, X., Kimura, H., Parada, L. F., & Harada, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914514107 · Cited by 84
Self-citationA novel mechanism for the regulation of amyloid precursor protein metabolism
Chen, Q., Kimura, H., & Schubert, D. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110151 · Cited by 63
Cited by
Dock protein family in brain development and neurological disease
Shi, L. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.26839 · Cited by 83
Dock GEFs and their therapeutic potential: Neuroprotection and axon regeneration
Namekata, K., Kimura, A., Kawamura, K., Harada, C., & Harada, T. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.06.005 · Cited by 57
Self-citationRho GTPases in neurodegeneration diseases
DeGeer, J., & Lamarche-Vane, N. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.016 · Cited by 46
Bai, Y., Xiang, X., Liang, C., & Shi, L. (2015) · BioMed Research International · doi:10.1155/2015/632450 · Cited by 40
Metadata
- Authors
- Bai, N., Hayashi, H., Aida, T., Namekata, K., Harada, T., Mishina, M., & Tanaka, K.
- Venue
- Molecular Brain
- Published
- 2013-05-04
- Volume
- 6
- Issue
- 1
- Pages
- 22-22
- ISSN
- 1756-6606 (ISSN-L)
- OpenAlex
- W2168991961
- Cited by
- 49
- References
- 7
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity. https://app.cochat.ai/papers/10.1186/1756-6606-6-22
- The paper
- Bai, N., Hayashi, H., Aida, T., Namekata, K., Harada, T., Mishina, M., & Tanaka, K. (2013). Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity. Molecular Brain. https://doi.org/10.1186/1756-6606-6-22
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.